Business Wire

Koya Medical Secures $26M in Series B Funding to Advance Portfolio of Active Compression Therapies for Lymphedema and Venous Disorders

OAKLAND, Calif.--(BUSINESS WIRE)--Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric platforms, today ...
Fox 5 San Diego

Koya Medical Presents Two Newly Published Clinical Studies for Dayspring® Active Compression Treatments for Lymphedema and Venous Disease at the AVLS 2022 Annual Congress

OAKLAND, Calif., Oct. 24, 2022 /PRNewswire/ -- Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric ...
Business Wire

Koya Medical Presents Positive Interim Data from Randomized Trial Comparing its Dayspring Lymphedema Treatment to Pneumatic Compression

Interim clinical trial data presented at American Vein and Lymphatic Society Annual Congress demonstrate patient preference, strong therapy adherence, improved quality-of-life measures, and reduction ...